Who owns Agios Pharmaceuticals, Inc.?
Institutional ownership of AGIO from SEC Form 13F filings across 170 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
170
13F holders
$1.40B
value, 2026 filers
63.9%
of shares outstanding (38.2M sh)
29
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of AGIO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6.5M | $239.6M | 0.0% | 10.8% | +12.2% |
| 2 | D. E. Shaw & Co., Inc. | 3.1M | $115.3M | 0.1% | 5.2% | +15.9% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.9M | $107.6M | 0.0% | 4.9% | +11.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 2.7M | $99.5M | 0.0% | 4.5% | -49.1% |
| 5 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 2.1M | $78.3M | 0.1% | 3.5% | +41.2% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.6M | $58.4M | 0.0% | 2.6% | +7.2% |
| 7 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.4M | $51.0M | 0.0% | 2.3% | +2.3% |
| 8 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.3M | $47.5M | 0.0% | 2.1% | -19.0% |
| 9 | GOLDMAN SACHS GROUP INC | 1.2M | $42.7M | 0.0% | 1.9% | +42.8% |
| 10 | UBS Group AG | 985,831 | $36.6M | 0.0% | 1.7% | +643.8% |
| 11 | MORGAN STANLEY | 963,256 | $35.7M | 0.0% | 1.6% | -0.4% |
| 12 | Nuveen, LLC | 873,560 | $32.4M | 0.0% | 1.5% | +20.9% |
| 13 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 810,530 | $30.1M | 0.0% | 1.4% | +223.6% |
| 14 | CITADEL ADVISORS LLC | 732,687 | $27.2M | 0.0% | 1.2% | +18.2% |
| 15 | Qube Research & Technologies Ltd | 597,638 | $22.2M | 0.0% | 1% | +218.5% |
| 16 | NORTHERN TRUST CORP | 554,709 | $20.6M | 0.0% | 0.9% | +8.9% |
| 17 | Sixth Street Partners Management Company, L.P.NEW | 538,128 | $20.0M | 3.4% | 0.9% | new |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 538,128 | $20.0M | 0.0% | 0.9% | +12.8% |
| 19 | TWO SIGMA INVESTMENTS, LP | 536,380 | $19.9M | 0.0% | 0.9% | +113.2% |
| 20 | Schonfeld Strategic Advisors LLC | 520,083 | $19.3M | 0.1% | 0.9% | +160.0% |
| 21 | BANK OF AMERICA CORP /DE/ | 507,869 | $18.8M | 0.0% | 0.9% | 0.0% |
| 22 | Point72 Asset Management, L.P.NEW | 506,344 | $18.8M | 0.0% | 0.8% | new |
| 23 | JANE STREET GROUP, LLC | 492,598 | $18.3M | 0.0% | 0.8% | -28.1% |
| 24 | Legal & General Group Plc | 434,719 | $16.1M | 0.0% | 0.7% | +2.5% |
| 25 | VANGUARD FIDUCIARY TRUST CO | 395,868 | $14.7M | 0.0% | 0.7% | +3.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.